Durmaz Lidya-Olgu, Brunner Susanne Eva, Meinzer Andreas, Krebs Thomas Franz, Bergholz Robert
Department of General, Visceral, Thoracic, Transplant and Pediatric Surgery, University Medical Center Schleswig-Holstein (UKSH), Kiel Campus, Arnold-Heller-Strasse 3, 24105 Kiel, Germany.
Department of Pediatric Surgery, Children's Hospital of Eastern Switzerland, Claudiusstrasse 6, 9006 St. Gallen, Switzerland.
Children (Basel). 2022 Mar 15;9(3):416. doi: 10.3390/children9030416.
(1) Background: The morbidity of gastroschisis is defined by exposure of unprotected intestines to the amniotic fluid leading to inflammatory damage and consecutive intestinal dysmotility, the viscero-abdominal disproportion which results in an abdomen too small to incorporate the herniated and often swollen intestine, and by associated pathologies, such as in complex gastroschisis. To prevent intestinal damage and to provide for growth of the abdominal cavity, fetal interventions such as amnio exchange, gastroschisis repair or covering have been evaluated in several animal models and human trials. This review aims to evaluate the reported techniques for the fetal treatment of gastroschisis by focusing on minimally invasive procedures. (2) Methods: We conducted a systematic database search, quality assessment and analyzed relevant articles which evaluate or describe surgical techniques for the prenatal surgical management of gastroschisis in animal models or human application. (3) Results: Of 96 identified reports, 42 eligible studies were included. Fetal interventions for gastroschisis in humans are only reported for EXIT procedures and amnio exchange. In animal models, particularly in the fetal sheep model, several techniques of open or minimally invasive repair of gastroschisis or covering the intestine have been described, with fetoscopic covering being the most encouraging. (4) Discussion: Although some promising minimally invasive techniques have been demonstrated in human application and animal models, most of them are still associated with relevant fetal morbidity and mortality and barely appear to be currently applicable in humans. Further research on specific procedures, instruments and materials is needed before any human application.
(1)背景:腹裂的发病率取决于未受保护的肠管暴露于羊水中,导致炎症损伤及后续的肠道运动障碍;还取决于内脏与腹壁比例失调,致使腹部过小,无法容纳突出且常肿胀的肠管;此外还与相关病理情况有关,如复杂型腹裂。为预防肠道损伤并促进腹腔生长,在多个动物模型和人体试验中对羊膜腔置换、腹裂修复或覆盖等胎儿干预措施进行了评估。本综述旨在聚焦微创手术,评估已报道的胎儿腹裂治疗技术。(2)方法:我们进行了系统的数据库检索、质量评估,并分析了评估或描述动物模型或人体应用中腹裂产前手术管理手术技术的相关文章。(3)结果:在96篇已识别的报告中,纳入了42项符合条件的研究。关于人类腹裂的胎儿干预措施仅报道了产时宫外治疗手术(EXIT)和羊膜腔置换。在动物模型中,特别是在胎羊模型中,已描述了几种腹裂开放或微创手术修复或肠管覆盖技术,其中胎儿镜覆盖最具前景。(4)讨论:尽管在人体应用和动物模型中已展示了一些有前景的微创手术技术,但其中大多数仍与相关的胎儿发病率和死亡率相关,目前几乎似乎不适用于人类。在进行任何人体应用之前,需要对特定程序、器械和材料进行进一步研究。